中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
19期
104-105,106
,共3页
米非司酮%米索前列醇%绝经后%取环术
米非司酮%米索前列醇%絕經後%取環術
미비사동%미색전렬순%절경후%취배술
Mifepristone%Misoprostol%Postmenopause%Ring intraoperative
目的：探讨绝经后妇女节育环取出的方法，比较米非司酮配伍米索前列醇、阴道塞用结合雌激素软膏用于绝经后节育环取环的效果。方法：回顾性分析本院近7年来绝经后要求取出节育环的妇女，共87例，分为三组，甲组32例，口服米非司酮50 mg，2次/d，共2 d，第3天用米索前列醇400μg 塞阴道；乙组30例，阴道涂敷结合雌激素软膏2 g，1次/d，共10 d；对照组25例，术前无处理。比较三组取环时情况及手术成功率。结果：甲组宫颈扩张情况、手术时间、术中出血量、手术成功率、术后腹痛持续时间与其他两组相比，差异有统计学意义（P<0.05）。乙组与对照组相比，宫颈扩张情况、手术成功率差异有统计学意义（P<0.05），而手术时间、术中出血量、术后腹痛持续时间无差异无统计学意义（P>0.05）。结论：米非司酮配伍米索前列醇用于绝经后节育环取环安全、有效、成功率高、副作用小，值得推广。阴道涂敷结合雌激素软膏在绝经后节育环取环上也有一定疗效。
目的：探討絕經後婦女節育環取齣的方法，比較米非司酮配伍米索前列醇、陰道塞用結閤雌激素軟膏用于絕經後節育環取環的效果。方法：迴顧性分析本院近7年來絕經後要求取齣節育環的婦女，共87例，分為三組，甲組32例，口服米非司酮50 mg，2次/d，共2 d，第3天用米索前列醇400μg 塞陰道；乙組30例，陰道塗敷結閤雌激素軟膏2 g，1次/d，共10 d；對照組25例，術前無處理。比較三組取環時情況及手術成功率。結果：甲組宮頸擴張情況、手術時間、術中齣血量、手術成功率、術後腹痛持續時間與其他兩組相比，差異有統計學意義（P<0.05）。乙組與對照組相比，宮頸擴張情況、手術成功率差異有統計學意義（P<0.05），而手術時間、術中齣血量、術後腹痛持續時間無差異無統計學意義（P>0.05）。結論：米非司酮配伍米索前列醇用于絕經後節育環取環安全、有效、成功率高、副作用小，值得推廣。陰道塗敷結閤雌激素軟膏在絕經後節育環取環上也有一定療效。
목적：탐토절경후부녀절육배취출적방법，비교미비사동배오미색전렬순、음도새용결합자격소연고용우절경후절육배취배적효과。방법：회고성분석본원근7년래절경후요구취출절육배적부녀，공87례，분위삼조，갑조32례，구복미비사동50 mg，2차/d，공2 d，제3천용미색전렬순400μg 새음도；을조30례，음도도부결합자격소연고2 g，1차/d，공10 d；대조조25례，술전무처리。비교삼조취배시정황급수술성공솔。결과：갑조궁경확장정황、수술시간、술중출혈량、수술성공솔、술후복통지속시간여기타량조상비，차이유통계학의의（P<0.05）。을조여대조조상비，궁경확장정황、수술성공솔차이유통계학의의（P<0.05），이수술시간、술중출혈량、술후복통지속시간무차이무통계학의의（P>0.05）。결론：미비사동배오미색전렬순용우절경후절육배취배안전、유효、성공솔고、부작용소，치득추엄。음도도부결합자격소연고재절경후절육배취배상야유일정료효。
Objective:To explore the postmenopausal women out of the coil method,compare the effect of compatibility misoprostol,mifepristone vagina with premarin ointment used for postmenopause ring intraoperative.Method:A total of 87 cases for postmenopause ring intraoperative nearly 7 years were analyzed retrospectively,they were divided into three groups,the group A was 32 cases,oral mifepristone 50 mg twice a day,a total of 2 d,3 days from rice suo forefront alcohol 400 μg plug vagina;the group B was 32 cases,vaginal coating,combined with the premarin ointment 2 g,once a day, a total of 10 d,the control group was 25 cases,preoperative without processing. The situation and success rate of surgery when you pick up the ring was compared among the three groups.Result:The cervical dilation,operative time,intraoperative blood loss,surgical success rate,duration of postoperative abdominal pain in group A compared with other two groups,had the significant difference(P<0.05). The group B was compared with the controu group, had the significant difference(P<0.05),but the operation time,intraoperative blood loss,duration of postoperative abdominal pain had no difference (P>0.05).Conclusion:Mifepristone combined with misoprostol for postmenopause ring intraoperative is safe,effective and high success rate,small side effects,it is worthy of promotion. Coating premarin ointment in postmenopause ring intraoperative also have certain curative effect.
